XML 454 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial instruments fair value risk (Tables)
 12 Months Ended
Dec. 31, 2023
Disclosure of detailed information about financial instruments [abstract]  
Summary of Fair Values of Financial Assets and Financial Liabilities
€ million€ million€ million€ million
Fair valueFair valueCarrying
amount		Carrying
amount
Fair values of financial assets and financial liabilities2023202220232022
Financial assets
Cash and cash equivalents4,159 4,326 4,159 4,326 
Financial assets at amortised cost1,415 1,004 1,415 1,004 
Financial assets at fair value through other comprehensive income609 407 609 407 
Financial assets at fair value through profit or loss
   Derivatives112 289 112 289 
   Other981 889 981 889 
7,276 6,915 7,276 6,915 
Financial liabilities
Bank loans and overdrafts(506)(519)(506)(519)
Bonds and other loans(26,112)(25,136)(26,692)(26,512)
Lease liabilities(1,395)(1,408)(1,395)(1,408)
Derivatives(494)(631)(494)(631)
Other financial liabilities(535)(418)(535)(418)
(29,042)(28,112)(29,622)(29,488)
Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category
For assets and liabilities which are carried at fair value, the classification of fair value calculations by category is summarised below:
€ million€ million€ million€ million€ million€ million€ million€ million
Notes
Level 1
2023
Level 1
2022
Level 2
2023
Level 2
2022
Level 3
2023
Level 3
2022
Total fair
value
2023
Total fair
value
2022
Assets at fair value
Financial assets at fair value through other comprehensive income17A163 5 4 3 442 399 609 407 
Financial assets at fair value through profit or loss:
    Derivatives(a)
16C– – 149 378 – – 149 378 
    Other 17A582 428 – – 399 461 981 889 
Liabilities at fair value
  Derivatives(b)
16C– – (559)(784)– – (559)(784)
  Contingent consideration14– – – – (157)(164)(157)(164)
(a)Includes €37 million (2022: €89 million) derivatives, reported within trade receivables, that hedge trading activities.
(b)Includes €(65) million (2022: €(153) million) derivatives, reported within trade payables, that hedge trading activities.
Summary of Reconciliation of Movements in Level 3 Valuations
€ million€ million
Reconciliation of movements in Level 3 valuations20232022
1 January696 748 
Gains/(losses) recognised in income statement(68)11 
Gains/(losses) recognised in other comprehensive income(8)55 
Purchases and new issues71 94 
Sales and settlements*(7)(212)
31 December684 696 
* Includes nil 2023 (2022: €(157) million) movement due to derecognition of Unilever Ventures' equity interest in Nutrafol before business combination (refer to note 21 for more details).